FDA Is Wrong Again: Mailed Abortion Drugs are Not Safe
The FDA’s clinical and scientific staff is repeatedly being led astray from its public health mission. It should be obvious to anyone that the cumulative safety profile of mifepristone predicts that the FDA’s political decision to allow mailing of abortion drugs for at-home use will lead to otherwise preventable morbidity and mortality in America’s women.
FDA Is Wrong Again: Mailed Abortion Drugs are Not Safe Read More